HIV-infected patients may soon be
able to switch from a branded one-pill combination of antiretroviral drugs to a
less expensive protocol that combines generic and branded drugs. Current
guidelines recommend HIV-infected people take the single-pill combination of
efavirenz (Sustiva), emtricitabine (Emtriva), and tenofovir (Atripla). The
cheaper three-pill regimen would include a generic version of efavirenz,
lamivudine (similar to emtricitabine), and Atripla. According to Rochelle
Walensky, MD, the United States could see a savings of $920 million in the
first year if every US resident on antiretroviral therapy switched to the
three-pill generic regimen.
However, Walensky noted that it is
harder to adhere to the schedule of taking three pills, and lack of adherence
can make treatment less effective. In addition, there is evidence that
lamivudine is less effective than emtricitabine, and patients are more likely
to develop resistance to lamivudine.
Massachusetts General Hospital
researchers compared the cost and effectiveness of no treatment with the
recommended single pill dose, a three-pill regimen, and an intermediate
treatment consisting of two pills. The two-pill alternative would include a
generic form of efavirenz and a branded combination of tenofovir and
emtricitabine (Truvada). An HIV-infected person who receives no treatment from
age 43 has a life expectancy of 4.05 quality-adjusted life-years (QALY). The branded
single-pill treatment results in 12.45 QALY, compared with 12.25 QALY for the
two-pill intermediate treatment, and 12.08 QALY for the three-pill generic
treatment.
Lifetime cost for the person taking
the branded one-pill dose is $342,800, whereas lifetime cost for the
generic-based three-pill regimen is estimated to be $300,300.
The full report, “Economic Savings
Versus Health Losses: The Cost-Effectiveness of Generic Antiretroviral Therapy
in the United States,” was published in the journal Annals of Internal Medicine
(2013; 158(2):84–92).
The Friends of AIDS Foundation is
dedicated to enhancing the quality of life for HIV positive individuals and
empowering people to make healthy choices to prevent the spread of the HIV
virus. To learn more about The Friends of AIDS Foundation, please visit: http://www.friendsofaids.org.
TOGETHER WE REMAIN STRONG!